Pharmala Biotech Holdings Inc.
MDMA
CNSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3,422.56% | -13.70% | 115.68% | -- | -- |
| Total Receivables | -61.48% | -34.14% | -5.15% | -- | -- |
| Inventory | 3,078.67% | 3,264.00% | 190.14% | -- | -- |
| Prepaid Expenses | -70.73% | -75.50% | -65.78% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 188.25% | 16.54% | 46.61% | -- | -- |
|
|
|||||
| Total Current Assets | 188.25% | 16.54% | 46.61% | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -81.25% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -4.98% | 3.12% | 9.66% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 48.06% | 6.69% | 20.51% | -- | -- |
|
|
|||||
| Total Accounts Payable | -48.74% | -51.72% | 7.60% | -- | -- |
| Total Accrued Expenses | -87.74% | -67.59% | -69.08% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 3.33% | 50.72% | -17.19% | -- | -- |
| Total Other Current Liabilities | 3.33% | 50.72% | -17.19% | -- | -- |
| Total Current Liabilities | -32.89% | -20.02% | -10.63% | -- | -- |
|
|
|||||
| Total Current Liabilities | -32.89% | -20.02% | -10.63% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -32.89% | -20.02% | -10.63% | -- | -- |
|
|
|||||
| Common Stock & APIC | 34.75% | 20.27% | 19.24% | -- | -- |
| Retained Earnings | -36.02% | -28.55% | -20.31% | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 116.67% | 22.23% | 43.67% | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 116.67% | 22.23% | 43.67% | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 116.67% | 22.23% | 43.67% | -- | -- |
|
|
|||||